Haploidentical hematopoietic transplantation: current status and future perspectives.
about
Haploidentical Stem Cell Transplantation in Adult Haematological MalignanciesHow do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationMilestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsImmunity to Infections after Haploidentical Hematopoietic Stem Cell TransplantationHaploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectivesDonor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation.Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in miceLong-lasting production of new T and B cells and T-cell repertoire diversity in patients with primary immunodeficiency who had undergone stem cell transplantation: a single-centre experience.Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsRace/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilizationAllogeneic hematopoietic stem cell transplantation in China: where we are and where to go.Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.Manifestations of immune tolerance in the human female reproductive tract.Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantationNovel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen.Haploidentical transplantation in patients with acquired aplastic anemia.T cell depletion in paediatric stem cell transplantation.EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.Haploidentical stem cell transplantation for the treatment of leukemia: current status.What are the latest advancements in acute myeloid leukemia therapy?Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.Transplantation: moving to the next level.Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.Correlation of rabbit antithymocyte globulin serum levels and clinical outcomes in children who received hematopoietic stem cell transplantation from an alternative donor.T-cell depletion: from positive selection to negative depletion in adult patients.CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity.Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.
P2860
Q26745527-912D46E8-01DD-4749-9CC2-AE3C2D474C69Q26748867-C3F27F7E-C9D9-4F01-9F78-37CB1F1D4644Q26852474-2A326F7B-181D-4856-81FC-3BD16DFBD872Q28067102-3E2E83AD-B330-4DA8-9664-3A9A6F22DD65Q28079606-889C1981-F41A-4B8F-BC63-E94289357E5FQ28080452-D9521D19-EE0A-43DA-A19A-B3E83473DA52Q33441698-EE0D2886-D251-4BC7-8FB1-09CF39341007Q33707337-97388865-1967-4F91-A6BF-2E6909B98AB4Q34729193-D0BF6F1F-C093-46EB-810D-5B450F36327CQ35743914-F2444094-2357-4246-9E93-F7C7F13043C9Q35834570-E9EE22AF-F1AB-4126-9F93-11A9E952AFEAQ35845470-FEE9C0E3-BA87-4B06-B3C9-5FCDB4BA7C6BQ35965199-786151D6-78F1-4CED-9C65-EE28866A5F2DQ36444440-EB65E3C1-12F0-408B-BDA4-90C8CCCB1F72Q36606027-1544B32B-C413-4E63-9907-B6D9C70E8127Q36731638-E9288F09-0D9B-4CF1-BA19-CF2DCCAC8552Q37323038-979900AF-1BFA-4FEB-BCED-C61D15F525C5Q37327622-B8D98AC7-644C-47EE-BF4A-2CEDB5ADC388Q37700973-C0E896A0-0137-4FFF-A948-9A89AD156232Q38066860-C110B2CC-DAA1-4A43-A28E-0AD9C5970F1CQ38071929-BD77CB46-BC6C-4B87-B873-2680035C7A68Q38097916-29554B7C-C762-4478-AB5B-B601435C4422Q38119843-E57FBBB0-02FE-4A82-A1DF-4D5D7131D34BQ38149725-A95A9F93-5864-45BE-A9F0-C2798AB94111Q38155240-2731A995-30D9-4FDA-9F90-69EBC653193FQ38190856-3759B6F1-77C3-4A46-B7C7-39075D740EEFQ38248521-55B23A34-6A05-4275-BC33-03E117EDEE83Q38749830-87B15FFF-AABD-44BE-A185-F27DC626C2B0Q38870274-2022737A-FD27-4190-9269-46E0AEF52D77Q38922475-184B1D48-EE12-4B21-93A2-8041F56BD2ABQ38953608-3928F9E2-A95C-4EDC-9419-1405C34B3CCBQ39305147-1A3562AB-C02D-4F2A-9DD3-846CB90F121FQ40043395-C99CAEEC-7A42-4EC7-AD46-84D05BEFFFA1Q40174651-5E5A0365-CE0C-400A-AAD5-DFF2C0C3E22DQ40466615-C6B19258-FCBF-4294-8245-AC55C28D4C93Q40929855-2634CDB9-B622-4670-8CA3-0601BA0D998AQ41697468-78BC8E62-1944-4093-BD95-0F7AC55C89A1Q41916538-00064082-9A9A-407C-9191-73A3A6BD4433Q42212281-5B2905DB-79E2-4F2E-85D4-DDCBC9D219CAQ42251937-E9616F1F-D71A-4C42-999D-982328A26B92
P2860
Haploidentical hematopoietic transplantation: current status and future perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Haploidentical hematopoietic transplantation: current status and future perspectives.
@en
Haploidentical hematopoietic transplantation: current status and future perspectives.
@nl
type
label
Haploidentical hematopoietic transplantation: current status and future perspectives.
@en
Haploidentical hematopoietic transplantation: current status and future perspectives.
@nl
prefLabel
Haploidentical hematopoietic transplantation: current status and future perspectives.
@en
Haploidentical hematopoietic transplantation: current status and future perspectives.
@nl
P2093
P1433
P1476
Haploidentical hematopoietic transplantation: current status and future perspectives.
@en
P2093
David Hagin
Massimo F Martelli
Yair Reisner
P304
P356
10.1182/BLOOD-2011-07-338822
P407
P577
2011-09-14T00:00:00Z